home / stock / mdclf / mdclf quote
Last: | $6.9757 |
---|---|
Change Percent: | 100.0% |
Open: | $0 |
Close: | $6.9757 |
High: | $0 |
Low: | $0 |
Volume: | 2,000 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$6.9757 | $0 | $6.9757 | $0 | $0 | 2,000 | 02-23-2024 |
$6.9757 | $0 | $6.9757 | $0 | $0 | 3,000 | 10-25-2023 |
$6.9757 | $6.9854 | $6.9757 | $7.0166 | $6.9746 | 21,644 | 07-31-2023 |
$10.8381 | $10.91 | $10.8381 | $11.1177 | $10.8003 | 25,000 | 05-02-2023 |
$9.7 | $0 | $9.7 | $0 | $0 | 34,434 | 09-16-2022 |
$9.7 | $0 | $9.7 | $0 | $0 | 8,828 | 09-15-2022 |
$9.7 | $0 | $9.7 | $0 | $0 | 1,680 | 09-14-2022 |
$9.7 | $0 | $9.7 | $0 | $0 | 26,702 | 09-13-2022 |
$9.7 | $0 | $9.7 | $0 | $0 | 22,031 | 08-29-2022 |
$9.7 | $0 | $9.7 | $0 | $0 | 995 | 08-26-2022 |
$9.7 | $0 | $9.7 | $0 | $0 | 51,886 | 08-25-2022 |
$14 | $14 | $14 | $14 | $14 | 100 | 10-18-2021 |
News, Short Squeeze, Breakout and More Instantly...
Medical Intelligence Technologies Inc Company Name:
MDCLF Stock Symbol:
OTCMKTS Market:
Medincell will receive an upfront payment of $35 million and is eligible for up to $1.9 billion in potential development and commercial milestones, plus royalties on worldwide sales. Medincell and AbbVie will co-develop, and AbbVie will commercialize up to six cutting-edge long-acting inj...
Global health agency Unitaid has awarded Medincell (Paris:MEDCL) an extension grant of up to US$ 6 million over three years to fund the clinical phase 1 activities of long-acting injectable mdc-STM. If proven safe, effective, and acceptable, mdc-STM could have a significant impact on transmission...
Guidance for 2024 UZEDY Teva’s revenue: ~ $80 million Olanzapine LAI ongoing Phase 3: 675 patients (recruitment completed), 62% of the targeted 3,600 injections performed, no PDSS (Post injection Delirium/Sedation Syndrome) observed MedinCell (Paris:MEDCL): Access...